Polyethylene glycol 3350, Sodium Ascorbate, Sodium Sulfate Anhydrous, Ascorbic Acid, Sodium Chloride, and Potassium Chloride Oral Solution — FDA Drug Shortage

To Be Discontinued — Salix Pharmaceuticals, a division of Bausch Health US, LLC

The FDA lists a drug shortage record for Polyethylene glycol 3350, Sodium Ascorbate, Sodium Sulfate Anhydrous, Ascorbic Acid, Sodium Chloride, and Potassium Chloride Oral Solution (oral solution) from Salix Pharmaceuticals, a division of Bausch Health US, LLC with status To Be Discontinued. The shortage was first posted on 08/13/2026.

Shortage Details

Status
To Be Discontinued
Company
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Package NDC
65649-400-01
Dosage Form
Oral Solution
Presentation
Plenvu, Oral Solution, KIT (NDC 65649-400-01)
Initial Posting
08/13/2026
Revised Date